Business Wire

CA-JUNIPER-NETWORKS

22.2.2024 12:01:30 CET | Business Wire | Press release

Share
Juniper Networks Selected by KK Networks for Sustainable Cloud Metro Network Deployment Delivering Superior Quality of Experience for Residential & Business Users

Juniper Networks (NYSE: JNPR), a leader in secure, AI-Native Networks, today announced that it is providing KK Networks, one of the fastest growing internet Service Providers (ISPs) in Pakistan, with a scalable and resilient Cloud Metro network. The network will provide residential users with affordable internet access and an enhanced quality of experience, while also providing a sustainable services delivery platform for KK Networks (KKN). KKN is also expanding its offering with business-grade internet services using the transformed network. The new, robust Cloud Metro infrastructure will cover extensive areas of Lahore, Pakistan with plans to extend further over time.

The company has also upgraded its data centers with state-of-the-art automation software and secure, high-performance platforms from Juniper to streamline and optimize the design, deployment and operations of the network fabric. This will complement the Cloud Metro platform, further enhancing the overall user experience at scale.

KKN is a fast-growing internet service provider that has rapidly evolved to accommodate the surging demand in Pakistan for digital services. Following a four-fold increase in its user base in Lahore in just two years, KKN needed a robust metro network to handle the increasing demand on bandwidth which today serves 140,000 residential customers and growing. Juniper’s Cloud Metro solution was chosen specifically to provide a platform that can scale alongside KKN’s continued traffic growth and support the distributed nature of its user base and therefore traffic patterns.

With its previous network, internet performance would often slow during peak hours. Frequent network congestion meant that subscribers’ internet connections would often drop. With a transformed metro network that keeps up with the pace and scale of demand, KKN can now deliver reliable internet connectivity with enhanced quality of experience for its subscribers. The company is continuing a high-growth trajectory with an opportunity to bring high-performance, differentiated internet services to thousands of homes and businesses in Pakistan.

KKN has an ongoing objective to help support and enhance the digital economy in Pakistan. Approximately half of the 230 million population is still without access to broadband internet services today, according to the Pakistan Telecom Authority. The Cloud Metro network from Juniper equips KKN to create reliable, high-quality digital connections that can improve economic opportunity, build a stronger community and foster better education. Juniper Cloud Metro’s compact and efficient system design enables KKN to deliver more energy-efficient operations. Additional to improving its own operational costs, this also bolsters its ability to offer affordable broadband for customers across the region.

News Highlights

  • KKN deployed the Juniper Cloud Metro solution to scale capacity, improve resiliency and deliver low-latency user experiences for residential and business services.
  • High-capacity Juniper ACX7100-32C Cloud Metro routers form the aggregation network, meeting KKN’s growth requirements with a compact, power-efficient design for operational efficiency.
  • The Juniper ACX710 Universal Metro Router is used for the access layer. As a compact, hardened platform, the ACX710 can be deployed indoors or outdoors. Its high port density and small footprint allow KKN to support a higher number of customers efficiently. Lower energy consumption means KKN can deliver its services more sustainably.
  • KKN also uses Juniper’s AI-driven, high-performance EX2300 Ethernet Switch to extend connectivity to its business customers. The cloud-ready EX switches are easy to onboard, configure and manage, ensuring quick and easy deployment for KKN’s business customers.
  • KKN uses Juniper QFX5120 switches for the data center underlay network, EVPN-VXLAN for the overlay network and EX2300s to create a data center fabric that supports up to 100GbE interfaces. This enables the network to keep pace with customer demand for content delivery, voice, video and other bandwidth-hungry services.
  • KKN plans to deploy Juniper Apstra™ intent-based networking software in its product roadmap, to automate and validate the design, deployment and operation of the data center fabric to ensure reliable operations. With multi-vendor support, Apstra will empower KKN to automate and manage networks across any data center location, vendor and topology.

Supporting Quotes

“KKN is determined to improve and expand internet services across Lahore, Pakistan, to ensure that our customers have the best digital experiences. With Juniper, our new Cloud Metro network has observed 99.9 per cent uptime, delivering an accessible, high-performance digital platform to 14 regions in Lahore. With this new low-latency, resilient network, KKN can continue to grow our customer base with confidence that residential and business customers can rely on great connectivity to a sustainable network that can handle the demand.”

- Imran Ali, CEO, KK Networks

“Juniper continuously strives to enable remarkable digital experiences for our customers’ users, and the Cloud Metro solution is a perfect example of our market-leading innovation, applying cloud principles to metro networks. KK Networks is undertaking a transformative journey, upgrading from a traditional “Retro Metro” that cannot keep up with demand for today’s digital services at scale, to Juniper’s high-performance Cloud Metro infrastructure that makes sustainable, future-proof business growth possible for service providers globally.”

- AE Natarajan, Executive Vice President, Juniper Networks

Additional Resources

Juniper Solution: Cloud Metro

About Juniper Networks

Juniper Networks believes that connectivity is not the same as experiencing a great connection. Juniper's AI-Native Networking Platform is built from the ground up across the AIOps layer and our systems to fully harness the power of AI. From real-time fault isolation to proactive anomaly detection and self-driving corrective actions, it provides campus, branch, data center, and WAN operations with next-level predictability, reliability, and security. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on X (Twitter), LinkedIn and Facebook.

Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240222111099/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye